Objectives/Hypothesis: Mesenchymal stem cells (MSCs) hold therapeutic promise for vocal fold scar, yet the precise mechanism(s) underlying tissue level changes remain unclear. We hypothesize that MSCs interact with native fibroblasts to favorably affect healing. Furthermore, we hypothesize that these interactions vary based on MSC source.
INTRODUCTION
Vocal fold (VF) fibrosis can result from various injuries, including phonotrauma, inflammation, or surgery. Given that optimal tissue pliability and viscoelasticity are required for normal voice, VF fibrosis can yield substantive dysphonia due to altered biomechanical properties. Changes to the extracellular matrix (ECM) associated with VF fibrosis include excessive collagen deposition, disorganized elastin, and loss of hyaluronic acid (HA). [1] [2] [3] These tissue changes pose a significant clinical challenge because current therapeutics remain suboptimal. Stem cell therapy has evolved in the field of regenerative medicine. Mesenchymal stem cells (MSCs) are considered a promising therapeutic tool, and clinical trials are currently underway for a variety of diseases, including myocardial ischemia, graft-versus-host diseases, liver cirrhosis, anemia, Alzheimer's disease, spinal cord injury, and ischemic stroke. 4 The main mechanism underlying the therapeutic effect of MSCs is likely paracrine effects via tropic factors with antifibrotic, antiapoptotic, and/or proangiogenic properties. 5 MSCs are safe and pose no ethical issues, particularly when employing an autologous source. Furthermore, isolation of MSCs is not challenging and can be obtained from a wide range of tissues. The regenerative efficacy of MSCs for vocal fold fibrosis has been previously reported in a variety of species [6] [7] [8] [9] [10] ; however, several critical foundational issues must be addressed, including cell source, cell quantity, and timing of delivery. A recent study described injection of adipose-derived stem cells (ASCs) and bone marrow-derived stem cells (BMSCs) into the injured rat VF submucosa. No differences were reported between cell type with regard to healing outcomes. 11 Insight into the utility of MSCs as a therapeutic tool for the management of vocal fold injury and repair is limited and warrants further investigation.
Wound healing involves a complex network of cells and extracellular components. Fibroblasts and myofibroblasts synthesize ECM and reconstruct the microenviroment following injury. 12 Mature myofibroblasts express alpha smooth muscle actin (a-SMA) and produce excessive collagen, yielding increased tissue stiffness. Persistent myofibroblast activation and collagen deposition underlies a variety of fibrotic processes. 13 Transforming growth factor (TGF)-b is a central mediator of myofibroblast differentiation, and increased TGF-b mRNA expression has been reported as early as 8 hours following VF injury. 14 shown to regulate the fibrotic phenotype in vocal fold fibroblasts; this response appears to be Smad3-dependent. 15 Conversely, hepatocyte growth factor (HGF) has been shown to be antifibrotic. Exogenous HGF enhanced histological and functional healing in both acute and more chronic vocal fold fibrosis in canine mode. 16, 17 In the current study, we hypothesized that MSCs regulate TGF-b signaling, HGF secretion, and ECM production in VF fibroblasts via paracrine signaling. We employed a coculture model to address this hypothesis. In addition, we hypothesized that these paracrine effects vary based on the source of MSCs (ASCs vs. BMSCs). Finally, we hypothesized that this paracrine signaling is likely bidirectional, with VFFs affecting MSC activity. Ultimately, exploiting the inherent cellular response following vocal fold injury to direct the wound healing toward a more regenerative outcome holds significant therapeutic promise.
MATERIALS AND METHODS

Isolation and Confirmation of Primary Culture
Following approval from the Institutional Animal Use and Care Committee at the New York University School of Medicine, Sprague-Dawley rats (5 females aged between 12 to 14 weeks) were employed to create primary culture of three cell types: vocal fold fibroblasts (VFFs), ASCs, and BMSCs. Isolation of VFFs was performed according to previously published methods. 18, 19 Briefly, the lamina propria and epithelia of the VFs were resected and minced under magnification. Isolation of MSCs was described previously. 11 ASCs were isolated from minced inguinal fat pads with Liberase (Roche, Indianapolis, IN) according to the manufacturer's protocol. BMSCs were obtained via bone marrow flush of the bilateral femurs. To extract cells, 10 mL fat pads and 2 mL of bone marrow was employed for the acquisition of ASCs and BMSCs, respectively. The solution containing ASCs was diluted five times prior to seeding and experimentation. All tissue was then cultured in Dulbecco's Modified Eagle's Medium (DMEM), supplemented with 10% fetal bovine serum and antibiotic/antimycotic at 378C under standard cell culture conditions. Once 80% confluence was achieved, the cells were trypsinized and passaged. Experimentation involved cells at passages 3 and 4. Characterization of MSCs was confirmed via rat MSC Functional Identification kit (R&D Systems, Minneapolis, MN). Trilineage differentiation into adipocytes, osteocytes, and chondrocytes was confirmed via positive staining for FABP4, osteocalcin, and aggrecan, respectively (Fig. 1) .
Coculture Model
Five cell lines from five rats were prepared. VFFs and MSCs were cultured separately for 24 hours to ensure adequate cell health. VFFs (1.0 3 10 4 ) were then seeded on 6-well plates. ASCs and BMSCs (both at 1.0 x 10 4 ) were seeded on cell culture inserts with 0.4 lm pores (Falcon, Corning, NY). Following 12 hours serum starvation (DMEM 1 0.1% bovine serum albumin), the plates were rinsed with phosphatebuffered saline (PBS), and the cells were treated with serumfree DMEM 6 TGF-b1 (10 ng/mL). The inserts containing MSCs were rinsed with PBS and gently transferred into 6-well plates containing VFFs. Control VFFs and MSCs were collected from the 6-well plates and from the inserts, respectively. Six experimental conditions were included: VFF control (VFF), VFFs with ASCs (VFF 1 ASC), and VFFs with BMSCs (VFF 1 BMSC) with or without TGF-b1. MSCs from the inserts were also harvested: ASC control (ASC), ASCs with VFFs (ASC 1 VFF), BMSC control (BMSC), and BMSCs with VFFs (BMSC 1 VFF) with or without TGF-b1. VFFs were individually cocultured with ASCs or BMSCs from the same animal. 
Cell Morphology
VFFs were imaged after 24 hours of coculture using a Nikon Eclipse TS100 microscope (Nikon, Inc. Melville, NY) with an attached C-mount Morrell HDMI-02 camera (103; Morrell Instrument Company, Melville, NY).
Quantitative Real-Time Polymerase Chain Reaction
After 6 hours of coculture, the inserts were removed and total RNA was extracted using the RNeasy Mini Kit (Qiagen, Valencia, CA). The quantity and quality of mRNA was evaluated via 260:280 ratio. RNA was reverse transcribed with a High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA). Quantitative polymerase chain reaction (PCR) employed the TaqMan Gene Expression kit (Life Technologies, Waltham, MA) and StepOne Plus (Applied Biosystems). Real time PCR (RT-PCR) was performed to investigate changes in gene expression of ECM components, select components of the TGF-b signaling pathway, as well as HGF expression. To quantify the interaction between VFFs and MSCs, RNA from ASCs and BMSCs on the inserts was also extracted. The following genes were amplified: procollagen type I (Col1a1) and III (Col3a1), matrix metalloproteinase (Mmp1a), hyaluronan synthase 1 (Has1), Has2 and Has3, Smad3, Tgf-b1, TGF-b1 receptor type I (Tgf-br1) and type II (Tgf-br2), and HGF (Hgf). The primer probes employed were:
, and Gapdh (Rn01775763_m1). All experiments included cells derived from five different animals run in triplicate. The DDCt method was employed with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the housekeeping gene.
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis
After 24 hours of coculture, the inserts were removed, and the plates were washed twice with cold PBS. VFFs were harvested via cell scraping and total cellular protein was extracted using the Mammalian Protein Extraction Reagent (Thermo Scientific, Waltham, MA), supplemented with Halt Protease inhibitor cocktail (Thermo Scientific), 0.5M EDTA Solution 1003 (Thermo Scientific), Calyculin A (Cell Signaling, Danvers, MA), and 2-mercaptoethanol (Life Technologies). Total protein was quantified via the Pierce 660nm Protein Assay (Thermo Scientific). Each protein lysate (0.5 mg) was loaded on 8% sodium dodecyl sulphate-polyacrylamide gels. Protein was transferred to polyvinylidene difluoride membranes (Invitrogen, Carlsbad, CA); the membranes were then blocked in nonfat milk overnight at 48C. The membranes were incubated with a primary antibody against a-SMA (Sigma, St Louis, MO; 1:10,000) or GAPDH (Cell Signaling, Danvers, MA; 1:1000) at 48C overnight followed by 1-hour incubation with horseradish peroxidase-conjugated secondary antibody (Cell Signaling). Blots were visualized using chemiluminescence detection and quantified via ImageJ Software (v1.41; National Institutes of Health, Bethesda, MD).
Statistical Analyses
For all analyses, the dependent variable of interest was subjected to a one-way analysis of variance. If the main effect was significant at P < 0.05, post hoc comparisons were performed via the Tukey-Kramer method. Statistical significance was defined as P < 0.01 or P < 0.05 using StatView 5.0 (SAS Institute, Berkeley, CA). All data are expressed as means 6 standard error.
RESULTS
Neither TGF-b1 nor coculture with MSCs altered VFF morphology. Cell morphology did not qualitatively change in response to TGF-b1 or either coculture condition (Fig. 2) .
Coculture With MSCs
This decrease, however, did not achieve statistical significance ( Fig. 3A and 3B ). Mmp1a trended toward increased expression in VFFs in both coculture environments but did not achieve significance (Fig. 3C ). All Has subtypes were significantly reduced in VFF 1 BMSC in response to TGF-b1 (Has1-P < 0.01, Has2-P < 0.05, and Has3-P < 0.05). Has3 decreased significantly in VFF 1 ASC with TGF-b1 treatment (P < 0.01) (Fig. 3D-F) .
VFFs Had Differential Effects on ASCs and BMSCs in Coculture
Phenotypic changes to MSCs were quantified to determine the effects of VFFs, with an emphasis on genes related to ECM metabolism. Col1a1 and Col3a1 gene expression decreased in ASC 1 VFF without TGF-b1 stimulation ( Fig. 4A and B) . Mmp1a, Has1, and Has2 mRNA significantly increased in BMSC 1 VFF, regardless of TGF-b1 stimulation. No effects were observed with regard to Has3 expression in either coculture condition or cell type (Fig. 4C-F) .
BMSCs Suppressed TGF-b Signaling and Upregulated HGF in VFFs
To investigate whether MSCs affect TGF-b signaling, Smad3 and TGF-b1 expression was quantified. In the absence of TGF-b1, Smad3 mRNA significantly decreased in VFF 1 BMSC compared to VFF control (P < 0.05). With TGF-b1 stimulation, however, Smad3 and Tgf-b1 mRNA were significantly downregulated (P < 0.01 and P < 0.05, respectively), and this response was more pronounced in VFF 1 BMSC compared to VFF 1 ASC (Fig.  5A and B) . To further characterize this response, mRNA for type I and II TGF-b receptors (Tgf-br1 and Tgf-br2) was quantified. Tgf-br1 significantly decreased in VFF 1 BMSC when compared to VFF control or VFF 1 BMSC (both P < 0.05) with TGF-b1 stimulation. No significant differences were observed in Tgf-br1 expression in the absence of TGF-b1 treatment. In addition, no changes in Tgf-br2 expression were observed across conditions or groups ( Fig. 5C and D) . We further focused on fibrosis and quantified Hgf expression because it has been previously shown to be antifibrotic in the vocal folds. 20, 21 Hgf expression significantly increased in VFFs in both coculture conditions regardless of TGF-b1 treatment. This effect achieved statistical significance in the VFF 1 ASC and VFF 1 BMSC conditions without TGF-b1 stimulation (P < 0.05 and P < 0.01, respectively) and in the VFF 1 BMSC condition with TGF-b1 stimulation (P < 0.01) (Fig. 5E) . 
MSCs Decreased Alpha-Smooth Muscle Actin in VFFs
To confirm the characteristic change of VFFs to myofibroblasts, a-SMA protein levels were assessed. a-SMA increased in VFFs in response to TGF-b1. This response, however, was blunted in both VFF 1 ASC and VFF 1 BMSC (Fig. 6A) . Quantification of these protein levels confirmed statistically significant decreased a-SMA levels in VFF 1 ASC and VFF 1 BMSC with TGFb1 stimulation (both P <0.01), as well as in the absence of TGF-b1 (both P < 0.05) (Fig. 6B) .
DISCUSSION
Vocal fold fibrosis continues to perplex clinicians. It is encouraging, however, that various therapeutic tools have shown efficacy in the laboratory. Among these novel tools, MSCs have gained increased attention across various fields given their capacity for tissue regeneration. MSCs are thought to contribute to the wound-healing response via their inherent capacity to secrete growth factors, cytokines, and chemokines. 22 We hypothesize that MSCs interact favorably with native vocal fold cells in the wound milieu. We employed a coculture model to quantify the interactions between MSCs and VFFs in vitro. In addition, given the fundamental role of secreted TGF-b in injured tissue, our coculture model included TGF-b1 exposure to recapitulate the injured VF microenviroment. Clinically, MSC transplantation is typically autologous. As such, our coculture model involved VFFs exposed to MSCs from the same animal. In this context, rats are an ideal animal model for this type of experimentation.
The tissue response following injury is typically described in three phases: inflammation, proliferation, and remodeling. ECM synthesis largely occurs during the proliferative phase. Collagen type III is produced as a temporary scaffold to encourage cell infiltration and is eventually replaced by collagen type I via proteolytic enzyme (MMP)-mediated biodegradation. Interestingly, vocal fold fibrosis differs from dermal scar with regard to increased collagen III expression well into the chronic reparative phase. This difference, in addition to increased collagen type I content, likely contributes to the altered biomechanical properties of scarred vocal folds.
3 Col1a1 and Col3a1 mRNA expression significantly decreased in VFFs cocultured with BMSCs under TGF-b1 stimulation. Down-regulation of Col1a1 and Col3a1 mRNA expression did not achieve significance in this model without TGF-b1 stimulation. Interestingly, both Col1a1 and Col3a1 expression was significantly down-regulated in cocultured ASCs without TGF-b stimulation. These data likely suggest that collagen mRNA expression in VFFs was suppressed via paracrine BMSC-mediated signaling, especially in the context of TGF-b-stimulation. It is possible that VFF-mediated signaling suppressed collagen expression in ASCs in the absence of TGF-b. Mmp1a mRNA significantly increased in BMSCs cocultured with VFFs regardless of TGF-b stimulation. These data likely indicate the initiation of enzymatic collagen degradation in our model.
HA is thought to be a key molecule in maintaining VF viscoelasticity. 23 Specifically, reduced HA in the human VF is correlated with changes to the viscoelastic properties. 24 Has is a HA synthesizing enzyme, and each subtype has differing molecular weight and enzymatic activity. 25 Has1 and Has2 have been shown to be upregulated in acute rat VF healing, whereas Has3 is upregulated in the more chronic phases of healing. 26 In the current study, Has2 mRNA expression significantly increased in VFF cocultured with BMSCs with TGF-b1 stimulation. In contrast, Has1 and Has3 expression in VFFs decreased in coculture with both MSC types. With regard to bidirectional paracrine signaling, Has1 and Has2 expression significantly increased in BMSCs cocultured with VFFs. These data likely indicate that HA synthesis is not only derived from existing cells in the wound bed, including fibroblasts and myofibroblasts stimulated via paracrine MSC signaling, but from MSCs via autocrine or VFF-induced paracrine effects. Given that several previous in vivo studies demonstrated HA restoration with MSC transplantation, 11 HA secretion from transplanted MSCs via autocrine signaling could potentially compensate for paracrine signaling-mediated VFF inactivity. As noted previously, the primary histological change in vocal fold fibrosis is excessive accumulation of collagen and decreased HA. Our data suggest that preferable phenotypic changes are induced via interaction between VFFs and MSCs.
In scar, excessive ECM deposition and fibroblastmyofibroblast differentiation occur in parallel. Prolonged myofibroblast presence in the wound bed is associated with excessive collagen deposition, increased tissue stiffness, and irreversible fibrosis. TGF-b is a central mediator of myofibroblast differentiation and ECM deposition and has been implicated as a prime mediator of fibrosis across tissue systems. TGF-b signaling is complex and mediated largely via the Smad family of signaling proteins. Activated TGF-b receptor leads to phosphorylation of R-Smads (Smad2/Smad3). Phosphorylated Smad2/ Smad3 then heterodimerize with Smad4 (Co-Smad) and Fig. 6 . Sodium dodecyl sulfate polyacrylamide gel electrophoresis for a-SMA in VFFs cocultured with adipose-derived stromal cells or bone marrow-derived stromal cells 6 TGF-b1; representative gel (A). a-SMA protein expression was quantified relative to GAPDH (B). Data presented as mean 6 standard errror of mean of assays run in triplicate (n 5 5; **P < 0.01, *P < 0.05). a-SMA 5 alpha smooth muscle actin; ASC 5 adipose-derived stem cell; BMSC 5 bone marrow-derived stem cell; GAPDH 5 glyceraldehyde-3-phosphate dehydrogenase; TGF-b1 5 transforming growth factor; VFF 5 vocal fold fibroblast.
translocate into the nucleus to regulate transcription. 27 Among these factors, Smad3 is thought to be a master regulator of fibrosis. 28 In the current study, Smad3 mRNA expression in VFFs significantly decreased when cocultured with BMSCs, with or without TGF-b stimulation. In addition, VFF expression of Tgf-b1 and Tgf-br1 decreased with Tgf-b1 stimulation when cocultured with BMSCs. These data are consistent with previous work, which described MSC-mediated suppression of R-Smads and endogenous TGF-b1 in glomerular fibrosis in vivo. 29 VFF expression of a-SMA, a myofibroblast marker, decreased in coculture with both ASCs and BMSCs. However, decreased TGF-b signaling genes were observed in VFFs cocultured with BMSCs under of TGF-b stimulation, but decreased a-SMA expression may in fact be preferable because it would indicate inhibition of myofibroblast differentiation upstream of TGF-b signaling. In this study, we further investigated changes in HGF expression in our coculture model. HGF expression was enhanced regardless of TGF-b1 stimulation. Exogenous HGF was previously reported to suppress a-SMA expression in VFFs. This inhibitory effect on differentiation was putatively suggested to be related to the antifibrotic effects of HGF. 30 Data from the current study concur with these previous data; decreased a-SMA expression in VFFs under coculture conditions may be related to HGF secretion as well as suppression of TGF-b signaling.
With regard to the source of MSCs, differences between the effects of ASCs and BMSCs on VFFs were observed. The magnitude of these effects tended to be greater with BMSCs; the paracrine effects of BMSCs were profound with regard to ECM regulation and suppression of TGF-b signaling. With regard to vocal fold fibrosis, ASCs were previously reported to hold increased therapeutic efficacy over BMSCs when combined with an atelocollagen scaffold. 31 In other fields, contrary data exist. 32, 33 These differences could be related to the selection of experimental conditions, including species, animal age, in vitro or in vivo setting, and timing of harvest. Cumulatively, however, the emerging data regarding the utility of MSCs in the context of vocal fold fibrosis are encouraging.
CONCLUSION
MSCs favorable effected VFFs in the context of TGF-b1 stimulation. Specifically, MSCs altered ECM metabolism, suppressed TGF-b signaling, and inhibited VFF myofibroblast differentiation. Although both ASCs and BMSCs had a favorable effect, BMSCs yielded more favorable effects on VFFs.
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